Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 3
1979 2
1981 1
1982 1
1983 1
1984 1
1985 6
1987 2
1988 1
1989 5
1990 3
1991 7
1992 2
1993 5
1994 1
1995 3
1996 6
1997 3
1998 2
1999 2
2000 2
2001 9
2002 5
2003 4
2004 8
2005 9
2006 9
2007 9
2008 9
2009 6
2010 10
2011 8
2012 9
2013 17
2014 10
2015 12
2016 16
2017 11
2018 14
2019 19
2020 38
2021 45
2022 35
Text availability
Article attribute
Article type
Publication date

Search Results

337 results
Results by year
Filters applied: . Clear all
Page 1
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer.
Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, Rullier E, Joshua Smith J, Marijnen C, Peters FP, van der Valk M, Beets-Tan R, Myint AS, Gerard JP, Bach SP, Ghadimi M, Hofheinz RD, Bujko K, Gani C, Haustermans K, Minsky BD, Ludmir E, West NP, Gambacorta MA, Valentini V, Buyse M, Renehan AG, Gilbert A, Sebag-Montefiore D, Rödel C. Fokas E, et al. Among authors: gambacorta ma. Nat Rev Clin Oncol. 2021 Dec;18(12):805-816. doi: 10.1038/s41571-021-00538-5. Epub 2021 Aug 4. Nat Rev Clin Oncol. 2021. PMID: 34349247 Review.
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.
Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, Di Nicolantonio F, Solit D, Bardelli A. Misale S, et al. Among authors: gambacorta m. Nature. 2012 Jun 28;486(7404):532-6. doi: 10.1038/nature11156. Nature. 2012. PMID: 22722830 Free PMC article.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Valtorta E, Martino C, Sartore-Bianchi A, Penaullt-Llorca F, Viale G, Risio M, Rugge M, Grigioni W, Bencardino K, Lonardi S, Zagonel V, Leone F, Noe J, Ciardiello F, Pinto C, Labianca R, Mosconi S, Graiff C, Aprile G, Frau B, Garufi C, Loupakis F, Racca P, Tonini G, Lauricella C, Veronese S, Truini M, Siena S, Marsoni S, Gambacorta M. Valtorta E, et al. Among authors: gambacorta m. Mod Pathol. 2015 Nov;28(11):1481-91. doi: 10.1038/modpathol.2015.98. Epub 2015 Oct 9. Mod Pathol. 2015. PMID: 26449765 Clinical Trial.
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti C, Ribero D, Russolillo N, Muratore A, Massucco P, Pisacane A, Molinaro L, Valtorta E, Sartore-Bianchi A, Risio M, Capussotti L, Gambacorta M, Siena S, Medico E, Sapino A, Marsoni S, Comoglio PM, Bardelli A, Trusolino L. Bertotti A, et al. Among authors: gambacorta m. Cancer Discov. 2011 Nov;1(6):508-23. doi: 10.1158/2159-8290.CD-11-0109. Epub 2011 Sep 2. Cancer Discov. 2011. PMID: 22586653 Free article.
Outcome measures in multimodal rectal cancer trials.
Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, Rödel C. Fokas E, et al. Among authors: gambacorta ma. Lancet Oncol. 2020 May;21(5):e252-e264. doi: 10.1016/S1470-2045(20)30024-3. Lancet Oncol. 2020. PMID: 32359501 Review.
Stereotactic body radiotherapy for painful spinal metastases.
Cellini F, Manfrida S, Gambacorta MA, Valentini V. Cellini F, et al. Among authors: gambacorta ma. Lancet Oncol. 2021 Sep;22(9):e384. doi: 10.1016/S1470-2045(21)00421-6. Lancet Oncol. 2021. PMID: 34478668 No abstract available.
IGRT in rectal cancer.
Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. Ippolito E, et al. Among authors: gambacorta ma. Acta Oncol. 2008;47(7):1317-24. doi: 10.1080/02841860802256459. Acta Oncol. 2008. PMID: 18661433 Review.
[Epoetin alfa in radiotherapy].
Trodella L, Balducci M, Gambacorta MA, Mantini G. Trodella L, et al. Among authors: gambacorta ma. Tumori. 1998 Nov-Dec;84(6 Suppl 1):S15-9. doi: 10.1177/03008916980846s103. Tumori. 1998. PMID: 10083890 Review. Italian.
A radiotherapy staff experience of gratitude during COVID-19 pandemic.
Marconi E, Chiesa S, Dinapoli L, Lepre E, Tagliaferri L, Balducci M, Frascino V, Casà C, Chieffo DPR, Gambacorta MA, Valentini V. Marconi E, et al. Among authors: gambacorta ma. Tech Innov Patient Support Radiat Oncol. 2021 Jun;18:32-34. doi: 10.1016/j.tipsro.2021.04.002. Epub 2021 May 4. Tech Innov Patient Support Radiat Oncol. 2021. PMID: 33969234 Free PMC article.
337 results